Spring Fertility’s Post

As a sonographer in Reproductive Endocrinology, my patients hold a special place in my heart. Their journeys start with uncertainty and the process can be long and hard. If you work with patients navigating infertility, give grace and be supportive. Infertility is not a bad word! We need to talk about it more because so many of my patients share that they wish thwy knew, sooner. Have you had your AMH checked? What about a semen analysis? Let's talk about it! #infertilityawareness #reproductivehealth #reproductivehealthprofessional #fertilitysonographer

⚕️ The Women’s Reproductive Health Study is recruiting women with polycystic ovary syndrome, a condition characterized by infrequent or prolonged menstrual periods or the production of abnormal amounts of male hormones. The information garnered from this study may help scientists learn to detect signs of hormone problems and prevent reproductive health disorders in women. For more on who can participate in this study and what is required, please visit the study’s webpage.

Reproductive endocrinology is a specialized branch of medicine that focuses on hormonal functioning in relation to reproduction and fertility. It encompasses the diagnosis and management of conditions such as infertility, polycystic ovary syndrome (PCOS), endometriosis, and hormonal imbalances affecting reproductive health. In the dynamic landscape of reproductive health, reproductive endocrinology stands as a beacon of hope and innovation for individuals and couples aspiring to build families. With advancements in technology and a deeper understanding of human physiology, the realm of reproductive endocrinology continues to evolve rapidly, offering new insights, treatments, and possibilities. This is why our team at OC Fertility is dedicated to regularly educating ourselves in reproductive endocrinology. We know that it’s vital for our patient's best interest to continue being progressive as a clinic and always thinking ahead to the future in reproductive medicine. We actively participate in training, seminars, and other educational activities throughout the year to continue learning and further our knowledge about reproductive endocrinology. Click our link below to read the complete blog post. https://buff.ly/3IYop4f #OCFertility #newblogpost #womeninscience #reproductivemedicine #IVF #stayeducated #CEU #foreverstudent #fertility

The Women’s Reproductive Health Study is recruiting women with polycystic ovary syndrome, a condition characterized by infrequent or prolonged menstrual periods or the production of abnormal amounts of male hormones. The information garnered from this study may help scientists learn to detect signs of hormone problems and prevent reproductive health disorders in women. For more on who can participate in this study and what is required, please visit the study’s webpage.

The Women’s Reproductive Health Study is recruiting women with polycystic ovary syndrome, a condition characterized by infrequent or prolonged menstrual periods or the production of abnormal amounts of male hormones. The information garnered from this study may help scientists learn to detect signs of hormone problems and prevent reproductive health disorders in women. For more on who can participate in this study and what is required, please visit the study’s webpage.

Reproductive endocrinology and Infertility is a specialized branch of medicine that focuses on hormonal functioning in relation to reproduction and fertility. It encompasses the diagnosis and treatment of conditions such as infertility, polycystic ovary syndrome (PCOS), endometriosis, and hormonal management affecting reproductive health and wellness. In the dynamic landscape of reproductive health, fertility treatments stand as a beacon of hope and innovation for individuals and couples aspiring to build families. With advancements in technology and a deeper understanding of human physiology, the realm of reproductive endocrinology continues to evolve at a rapid pace, offering new insights, treatments, and possibilities. This is why our team at OC Fertility + OC Biogenix is dedicated to educating ourselves and our patients on a regular basis in our field of reproductive medicine. We know that it’s vital for our patient’s best interest to continue being progressive as a clinic and always think ahead to the future. We actively participate in training, seminars, networking, and educational activities throughout the year to continue to learn and further our own knowledge. Check out our latest blog post to read the full blog post today. https://bit.ly/4clRJjm #OCFertility #reproductivemedicine #fertilityeducation #fertility #fertilityservices #infertility #IVF

For the first time in history, Singapore's total fertility rate (TFR) has dipped below 1.0, reaching 0.97 in 2023—a decline from the previous records of 1.04 in 2022 and 1.12 in 2021. Besides Singapore, we also see countries like Japan, Thailand, Macau, and China reporting declining fertility and birth rates. In response to the urgent challenge of declining fertility and birth rates, Thomson Medical Group unites global leading fertility experts to discuss the complexities and opportunities within reproductive medicine. Join us at the upcoming Thomson Fertility Conference on 11 May to explore advancements in male and female infertility, ART techniques, reproductive endocrinology, and the promotion of equitable access to fertility care. Whether you're involved in groundbreaking research or leading patient care efforts, this conference offers a platform for medical professionals like you to gain unique insights from global fertility experts. Registration for this conference closes on 8 May 2024. Don't miss out—register now: https://lnkd.in/gB_XcKua. #ThomsonMedicalGroup #ThomsonFertilityConference #DoctorsConference #ReproductiveMedicine #GlobalLeadership

As educational attainment rises and professional opportunities expand across Southeast Asia, more couples are making the decision to delay starting families or to have fewer children. This shift reflects a significant cultural transformation, leading to declining birth and fertility rates throughout the region. In Malaysia, the evidence of change over the past fifty years is profound. The fertility rate has plummeted from an average of 4.9 children per woman in 1970 to just 1.6 in 2023. Similarly, in Vietnam, the birth rate has declined to 15.141 births per 1,000 people in 2023, marking a 2.33% decrease from the previous year. Singapore's scenario also highlights this regional trend. Despite government incentives aimed at boosting fertility, the fertility rate in this highly educated city-state remains stubbornly low, around 1.1 in recent years, well below the replacement level of 2.1 that is needed to sustain the population. This evolving dynamic speaks to a broader narrative of choice and planning, reflecting how couples are reshaping their futures and family structures in today’s changing world. Join us as Thomson Medical Group gathers global fertility experts at the upcoming Thomson Fertility Conference on 11 May. Together, we are spearheading discussions on advancements in reproductive medicine to confront pressing challenges in the field. From exploring The Role of Reproductive Surgery in the Era of Assisted Reproductive Technology (ART) to Updates on In Vitro Maturation (IVM), gain insights from unique Southeast Asian perspectives presented by esteemed global fertility experts.   Registration for this conference closes on 8 May 2024. Don't miss out—secure your spot now: https://lnkd.in/gPPkbShE.    #ThomsonMedicalGroup #ThomsonFertilityConference #DoctorsConference #ReproductiveMedicine #GlobalLeadership

The landscape of fertility care has evolved significantly in the past decade, driven by technological advancements, cultural shifts, and the challenges of the pandemic. Dr. Julie Rios, head of the Center for Fertility and Reproductive Endocrinology at UPMC Magee-Womens Hospital, highlights the changes and challenges they've navigated. From a significant patient backlog to the surge in demand for fertility services, including egg preservation, the field is constantly adapting. Dr. Rios emphasizes the importance of patient-centered care, balancing autonomy with medical expertise, and leveraging tools like online calculators to guide decision-making. Read more about the evolving landscape of fertility care here: https://bit.ly/3NdGHlB

The fertility workforce shortage is a complex issue that demands collaborative solutions from all stakeholders to optimize patient care now and in the future. While strategies like shortening fellowships or expanding OB-GYNs' roles show promise for increasing specialist availability in the near term, professional societies like the Society for Reproductive Endocrinology and Infertility (SREI) and the American Society for Reproductive Medicine - ASRM (ASRM) emphasize the need to balance this with preserving rigorous training standards and prioritizing patient care. "Our lens is that of what's best for patients...and what's best for our trainees so that they can go out and optimize patient care," states SREI President Erica Marsh Finding the right balance between increasing access and upholding quality will require open dialogue and aligning incentives across academia, private practices, and industry partners. At LEVY Health, we are contributing to this effort by empowering OB-GYNs to diagnose endocrine disorders and triage patients to the appropriate specialist at the right point in their care journey, helping them become parents faster. The discussion continues on addressing this specialist shortage in a responsible way that best serves patients' needs. Link to the white paper here: https://lnkd.in/ee9VXKwq #InfertilityAwareness #ReproductiveHealth #FertilityTech #IVF #FertilityInnovation